45 related articles for article (PubMed ID: 35752205)
1.
García LCA; Pérez MG; Ancarola ME; Rosenzvit MC; Cucher MA
Parasitology; 2022 Nov; 149(13):1775-1780. PubMed ID: 36165285
[No Abstract] [Full Text] [Related]
2. Understanding the pathogenic mechanisms and therapeutic effects in neurocysticercosis.
Castillo G; Fustamante L; Delgado-Kamiche AD; Camen-Orozco RP; Clark T; Bernal E; Morales-Alvarez J; Ferrufino M; Mamani-Palomino J; Bustos JA; Garcia HH; Gavidia CM; Gilman RH; Verastegui M;
Brain Pathol; 2024 Jan; ():e13237. PubMed ID: 38212958
[TBL] [Abstract][Full Text] [Related]
3. Sexual dimorphism in the murine model of extraparenchymal neurocysticercosis.
Moreira CAA; Murayama LHV; Martins TC; Oliveira VT; Generoso D; Machado VMV; Batah SS; Fabro AT; Bazan R; Zanini MA; Sciutto E; Fleury A; Hamamoto Filho PT
Parasitol Res; 2023 Sep; 122(9):2147-2154. PubMed ID: 37428312
[TBL] [Abstract][Full Text] [Related]
4. Chronic administration of cryptolepine nanoparticle formulation alleviates seizures in a neurocysticercosis model.
Mante PK; Adomako NO; Antwi P; Kusi-Boadum NK
Curr Res Pharmacol Drug Discov; 2021; 2():100040. PubMed ID: 34909669
[TBL] [Abstract][Full Text] [Related]
5. Combined Albendazole and Praziquantel Therapy in an Adult Female with Neurocysticercosis and Generalized Tonic-clonic Seizures.
Petrov K; Ihongbe F; Chang M; Choudhary S; Bhatia D
Cureus; 2018 Jul; 10(7):e2996. PubMed ID: 30245950
[TBL] [Abstract][Full Text] [Related]
6. Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.
Zhu HX; Li YC; Yang XP; Chu YH; Guo W; Chen RX; Guo DD; Cheng LJ; Li Y
Saudi J Med Med Sci; 2023; 11(4):283-291. PubMed ID: 37970452
[TBL] [Abstract][Full Text] [Related]
7. Effect of Hydroxyurea on Morphology, Proliferation, and Protein Expression on
Rios-Valencia DG; Estrada K; Calderón-Gallegos A; Tirado-Mendoza R; Bobes RJ; Laclette JP; Cabrera-Bravo M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892261
[TBL] [Abstract][Full Text] [Related]
8. Vertigo: An Atypical Presentation of Neurocysticercosis Successfully Treated With Albendazole.
Mesa E; Ruprecht V; Nguyen MC; Casadesus D
Cureus; 2023 Sep; 15(9):e45722. PubMed ID: 37868522
[TBL] [Abstract][Full Text] [Related]
9. Variation of the 2D Pattern of Brain Proteins in Mice Infected with
Díaz-Zaragoza M; Hernández-Ávila R; Landa A; Ostoa-Saloma P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338740
[TBL] [Abstract][Full Text] [Related]
10. Partial inhibition of the main energetic pathways and its metabolic consequences after
Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC
Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189
[TBL] [Abstract][Full Text] [Related]
11. Current approaches to cysticidal drug therapy for neurocysticercosis.
Del Brutto OH
Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of neurocysticercosis: a review].
Nogales-Gaete J; Arriagada C; Salinas R
Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
[TBL] [Abstract][Full Text] [Related]
13. Oxfendazole induces protein catabolism and gluconeogenesis in experimental neurocysticercosis.
Correia LTB; de Lima NF; Gomes TC; De Sousa Guerra CH; Costa TL; Vinaud MC
Acta Trop; 2022 Oct; 234():106571. PubMed ID: 35752205
[TBL] [Abstract][Full Text] [Related]
14. Oral nitazoxanide treatment of experimental neurocysticercosis induces gluconeogenesis in Taenia crassiceps cysticerci.
Lima NF; Picanço GA; Alves DSMM; Silva LD; Isac E; Costa TL; Lino Junior RS; Vinaud MC
Acta Trop; 2019 Feb; 190():361-364. PubMed ID: 30553893
[TBL] [Abstract][Full Text] [Related]
15. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.
Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC
Exp Parasitol; 2024 Jul; 262():108764. PubMed ID: 38677580
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
